Analysts have been eager to weigh in on the Healthcare sector with new ratings on Pfizer (PFE – Research Report) and 9 Meters Biopharma (NMTR – Research Report). Pfizer (PFE) In a report released yesterday, Carter Gould from Barclays maintained a Hold rating on Pfizer, with a price target of $52.00. The company's shares closed last Monday at $50.67. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-pfizer-pfe-and-9-meters-biopharma-nmtr?utm_source=advfn.com&utm_medium=referral
9 Meters Biopharma (NASDAQ:NMTR)
Historical Stock Chart
From Nov 2022 to Dec 2022 Click Here for more 9 Meters Biopharma Charts.
9 Meters Biopharma (NASDAQ:NMTR)
Historical Stock Chart
From Dec 2021 to Dec 2022 Click Here for more 9 Meters Biopharma Charts.